SPRYCEL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Dasatinib.
Product ID | 0003-0852_08c1dd2b-39d5-4adc-96b2-2985fdc6c142 |
NDC | 0003-0852 |
Product Type | Human Prescription Drug |
Proprietary Name | SPRYCEL |
Generic Name | Dasatinib |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2008-05-30 |
Marketing Category | NDA / NDA |
Application Number | NDA021986 |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | DASATINIB |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2008-05-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021986 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-05-30 |
Marketing Category | NDA |
Application Number | NDA021986 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-06-03 |
Marketing End Date | 2011-01-26 |
Ingredient | Strength |
---|---|
DASATINIB | 100 mg/1 |
SPL SET ID: | 4764f37b-c9e6-4ede-bcc2-8a03b7c521df |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0003-0524 | SPRYCEL | dasatinib |
0003-0527 | SPRYCEL | dasatinib |
0003-0528 | SPRYCEL | dasatinib |
0003-0852 | SPRYCEL | dasatinib |
0003-0855 | SPRYCEL | dasatinib |
0003-0857 | SPRYCEL | dasatinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SPRYCEL 78813186 3357619 Live/Registered |
Bristol-Myers Squibb Company 2006-02-13 |
SPRYCEL 78140234 3114787 Live/Registered |
Bristol-Myers Squibb Company 2002-07-01 |
SPRYCEL 77941220 3845228 Live/Registered |
Bristol-Myers Squibb Company 2010-02-22 |
SPRYCEL 77284740 not registered Dead/Abandoned |
Bristol-Myers Squibb Company 2007-09-20 |